Selected research
Market Analysis & Forecast
Global Cloud Computing in Clinical Trials Market Analysis and Forecast 2026-2032
Market perspective
The global Cloud Computing in Clinical Trials market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Cloud Computing in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cloud Computing in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cloud Computing in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cloud Computing in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Cloud Computing in Clinical Trials include Amazon Web Services (AWS), Google, Microsoft Azure, IBM Cloud, Curavit, Empiric Logic, Medable, Medidata and CliniciaRx, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Cloud Computing in Clinical Trials, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cloud Computing in Clinical Trials, also provides the revenue of main regions and countries. Of the upcoming market potential for Cloud Computing in Clinical Trials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cloud Computing in Clinical Trials revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cloud Computing in Clinical Trials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cloud Computing in Clinical Trials revenue, projected growth trends, production technology, application and end-user industry.
Cloud Computing in Clinical Trials Segment by Company
Amazon Web Services (AWS)
Microsoft Azure
IBM Cloud
Curavit
Empiric Logic
Medable
Medidata
CliniciaRx
Oracle Cloud Infrastructure (OCI)
POC Pharma
thrive
uMotif
Veeva
Cloud Computing in Clinical Trials Segment by Type
Public Cloud
Private Cloud
Hybrid Cloud
Cloud Computing in Clinical Trials Segment by Application
Clinical Trial Management Systems (CTMS)
Electronic Data Capture (EDC)
Regulatory Compliance
Data Analytics
Remote Patient Monitoring (RPM)
Cloud Computing in Clinical Trials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cloud Computing in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cloud Computing in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cloud Computing in Clinical Trials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Cloud Computing in Clinical Trials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Cloud Computing in Clinical Trials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cloud Computing in Clinical Trials revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Public Cloud
- Private Cloud
- Hybrid Cloud
Applications
- Clinical Trial Management Systems (CTMS)
- Electronic Data Capture (EDC)
- Regulatory Compliance
- Data Analytics
- Remote Patient Monitoring (RPM)
Companies covered
- Amazon Web Services (AWS)
- Microsoft Azure
- IBM Cloud
- Curavit
- Empiric Logic
- Medable
- Medidata
- CliniciaRx
- Oracle Cloud Infrastructure (OCI)
- POC Pharma
- thrive
- uMotif
- Veeva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cloud Computing in Clinical Trials Market by Type
- 1.2.1 Global Cloud Computing in Clinical Trials Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Public Cloud
- 1.2.3 Private Cloud
- 1.2.4 Hybrid Cloud
- 1.3 Cloud Computing in Clinical Trials Market by Application
- 1.3.1 Global Cloud Computing in Clinical Trials Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Clinical Trial Management Systems (CTMS)
- 1.3.3 Electronic Data Capture (EDC)
- 1.3.4 Regulatory Compliance
- 1.3.5 Data Analytics
- 1.3.6 Remote Patient Monitoring (RPM)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cloud Computing in Clinical Trials Market Dynamics
- 2.1 Cloud Computing in Clinical Trials Industry Trends
- 2.2 Cloud Computing in Clinical Trials Industry Drivers
- 2.3 Cloud Computing in Clinical Trials Industry Opportunities and Challenges
- 2.4 Cloud Computing in Clinical Trials Industry Restraints
3 Global Growth Perspective
- 3.1 Global Cloud Computing in Clinical Trials Market Perspective (2021-2032)
- 3.2 Global Cloud Computing in Clinical Trials Growth Trends by Region
- 3.2.1 Global Cloud Computing in Clinical Trials Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cloud Computing in Clinical Trials Market Size by Region (2021-2026)
- 3.2.3 Global Cloud Computing in Clinical Trials Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Cloud Computing in Clinical Trials Revenue by Players
- 4.1.1 Global Cloud Computing in Clinical Trials Revenue by Players (2021-2026)
- 4.1.2 Global Cloud Computing in Clinical Trials Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Cloud Computing in Clinical Trials Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cloud Computing in Clinical Trials Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Cloud Computing in Clinical Trials Key Players Headquarters & Area Served
- 4.4 Global Cloud Computing in Clinical Trials Players, Product Type & Application
- 4.5 Global Cloud Computing in Clinical Trials Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Cloud Computing in Clinical Trials Market CR5 and HHI
- 4.6.3 2025 Cloud Computing in Clinical Trials Tier 1, Tier 2, and Tier 3
5 Cloud Computing in Clinical Trials Market Size by Type
- 5.1 Global Cloud Computing in Clinical Trials Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Cloud Computing in Clinical Trials Revenue by Type (2021-2032)
- 5.3 Global Cloud Computing in Clinical Trials Revenue Market Share by Type (2021-2032)
6 Cloud Computing in Clinical Trials Market Size by Application
- 6.1 Global Cloud Computing in Clinical Trials Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Cloud Computing in Clinical Trials Revenue by Application (2021-2032)
- 6.3 Global Cloud Computing in Clinical Trials Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Amazon Web Services (AWS)
- 7.1.1 Amazon Web Services (AWS) Company Information
- 7.1.2 Amazon Web Services (AWS) Business Overview
- 7.1.3 Amazon Web Services (AWS) Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.1.4 Amazon Web Services (AWS) Cloud Computing in Clinical Trials Product Portfolio
- 7.1.5 Amazon Web Services (AWS) Recent Developments
- 7.2 Google
- 7.2.1 Google Company Information
- 7.2.2 Google Business Overview
- 7.2.3 Google Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.2.4 Google Cloud Computing in Clinical Trials Product Portfolio
- 7.2.5 Google Recent Developments
- 7.3 Microsoft Azure
- 7.3.1 Microsoft Azure Company Information
- 7.3.2 Microsoft Azure Business Overview
- 7.3.3 Microsoft Azure Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.3.4 Microsoft Azure Cloud Computing in Clinical Trials Product Portfolio
- 7.3.5 Microsoft Azure Recent Developments
- 7.4 IBM Cloud
- 7.4.1 IBM Cloud Company Information
- 7.4.2 IBM Cloud Business Overview
- 7.4.3 IBM Cloud Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.4.4 IBM Cloud Cloud Computing in Clinical Trials Product Portfolio
- 7.4.5 IBM Cloud Recent Developments
- 7.5 Curavit
- 7.5.1 Curavit Company Information
- 7.5.2 Curavit Business Overview
- 7.5.3 Curavit Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.5.4 Curavit Cloud Computing in Clinical Trials Product Portfolio
- 7.5.5 Curavit Recent Developments
- 7.6 Empiric Logic
- 7.6.1 Empiric Logic Company Information
- 7.6.2 Empiric Logic Business Overview
- 7.6.3 Empiric Logic Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.6.4 Empiric Logic Cloud Computing in Clinical Trials Product Portfolio
- 7.6.5 Empiric Logic Recent Developments
- 7.7 Medable
- 7.7.1 Medable Company Information
- 7.7.2 Medable Business Overview
- 7.7.3 Medable Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.7.4 Medable Cloud Computing in Clinical Trials Product Portfolio
- 7.7.5 Medable Recent Developments
- 7.8 Medidata
- 7.8.1 Medidata Company Information
- 7.8.2 Medidata Business Overview
- 7.8.3 Medidata Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.8.4 Medidata Cloud Computing in Clinical Trials Product Portfolio
- 7.8.5 Medidata Recent Developments
- 7.9 CliniciaRx
- 7.9.1 CliniciaRx Company Information
- 7.9.2 CliniciaRx Business Overview
- 7.9.3 CliniciaRx Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.9.4 CliniciaRx Cloud Computing in Clinical Trials Product Portfolio
- 7.9.5 CliniciaRx Recent Developments
- 7.10 Oracle Cloud Infrastructure (OCI)
- 7.10.1 Oracle Cloud Infrastructure (OCI) Company Information
- 7.10.2 Oracle Cloud Infrastructure (OCI) Business Overview
- 7.10.3 Oracle Cloud Infrastructure (OCI) Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.10.4 Oracle Cloud Infrastructure (OCI) Cloud Computing in Clinical Trials Product Portfolio
- 7.10.5 Oracle Cloud Infrastructure (OCI) Recent Developments
- 7.11 POC Pharma
- 7.11.1 POC Pharma Company Information
- 7.11.2 POC Pharma Business Overview
- 7.11.3 POC Pharma Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.11.4 POC Pharma Cloud Computing in Clinical Trials Product Portfolio
- 7.11.5 POC Pharma Recent Developments
- 7.12 thrive
- 7.12.1 thrive Company Information
- 7.12.2 thrive Business Overview
- 7.12.3 thrive Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.12.4 thrive Cloud Computing in Clinical Trials Product Portfolio
- 7.12.5 thrive Recent Developments
- 7.13 uMotif
- 7.13.1 uMotif Company Information
- 7.13.2 uMotif Business Overview
- 7.13.3 uMotif Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.13.4 uMotif Cloud Computing in Clinical Trials Product Portfolio
- 7.13.5 uMotif Recent Developments
- 7.14 Veeva
- 7.14.1 Veeva Company Information
- 7.14.2 Veeva Business Overview
- 7.14.3 Veeva Cloud Computing in Clinical Trials Revenue and Gross Margin (2021-2026)
- 7.14.4 Veeva Cloud Computing in Clinical Trials Product Portfolio
- 7.14.5 Veeva Recent Developments
8 North America
- 8.1 North America Cloud Computing in Clinical Trials Revenue (2021-2032)
- 8.2 North America Cloud Computing in Clinical Trials Revenue by Type (2021-2032)
- 8.2.1 North America Cloud Computing in Clinical Trials Revenue by Type (2021-2026)
- 8.2.2 North America Cloud Computing in Clinical Trials Revenue by Type (2027-2032)
- 8.3 North America Cloud Computing in Clinical Trials Revenue Share by Type (2021-2032)
- 8.4 North America Cloud Computing in Clinical Trials Revenue by Application (2021-2032)
- 8.4.1 North America Cloud Computing in Clinical Trials Revenue by Application (2021-2026)
- 8.4.2 North America Cloud Computing in Clinical Trials Revenue by Application (2027-2032)
- 8.5 North America Cloud Computing in Clinical Trials Revenue Share by Application (2021-2032)
- 8.6 North America Cloud Computing in Clinical Trials Revenue by Country
- 8.6.1 North America Cloud Computing in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Cloud Computing in Clinical Trials Revenue by Country (2021-2026)
- 8.6.3 North America Cloud Computing in Clinical Trials Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Cloud Computing in Clinical Trials Revenue (2021-2032)
- 9.2 Europe Cloud Computing in Clinical Trials Revenue by Type (2021-2032)
- 9.2.1 Europe Cloud Computing in Clinical Trials Revenue by Type (2021-2026)
- 9.2.2 Europe Cloud Computing in Clinical Trials Revenue by Type (2027-2032)
- 9.3 Europe Cloud Computing in Clinical Trials Revenue Share by Type (2021-2032)
- 9.4 Europe Cloud Computing in Clinical Trials Revenue by Application (2021-2032)
- 9.4.1 Europe Cloud Computing in Clinical Trials Revenue by Application (2021-2026)
- 9.4.2 Europe Cloud Computing in Clinical Trials Revenue by Application (2027-2032)
- 9.5 Europe Cloud Computing in Clinical Trials Revenue Share by Application (2021-2032)
- 9.6 Europe Cloud Computing in Clinical Trials Revenue by Country
- 9.6.1 Europe Cloud Computing in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Cloud Computing in Clinical Trials Revenue by Country (2021-2026)
- 9.6.3 Europe Cloud Computing in Clinical Trials Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Cloud Computing in Clinical Trials Revenue (2021-2032)
- 10.2 China Cloud Computing in Clinical Trials Revenue by Type (2021-2032)
- 10.2.1 China Cloud Computing in Clinical Trials Revenue by Type (2021-2026)
- 10.2.2 China Cloud Computing in Clinical Trials Revenue by Type (2027-2032)
- 10.3 China Cloud Computing in Clinical Trials Revenue Share by Type (2021-2032)
- 10.4 China Cloud Computing in Clinical Trials Revenue by Application (2021-2032)
- 10.4.1 China Cloud Computing in Clinical Trials Revenue by Application (2021-2026)
- 10.4.2 China Cloud Computing in Clinical Trials Revenue by Application (2027-2032)
- 10.5 China Cloud Computing in Clinical Trials Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cloud Computing in Clinical Trials Revenue (2021-2032)
- 11.2 Asia Cloud Computing in Clinical Trials Revenue by Type (2021-2032)
- 11.2.1 Asia Cloud Computing in Clinical Trials Revenue by Type (2021-2026)
- 11.2.2 Asia Cloud Computing in Clinical Trials Revenue by Type (2027-2032)
- 11.3 Asia Cloud Computing in Clinical Trials Revenue Share by Type (2021-2032)
- 11.4 Asia Cloud Computing in Clinical Trials Revenue by Application (2021-2032)
- 11.4.1 Asia Cloud Computing in Clinical Trials Revenue by Application (2021-2026)
- 11.4.2 Asia Cloud Computing in Clinical Trials Revenue by Application (2027-2032)
- 11.5 Asia Cloud Computing in Clinical Trials Revenue Share by Application (2021-2032)
- 11.6 Asia Cloud Computing in Clinical Trials Revenue by Country
- 11.6.1 Asia Cloud Computing in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Cloud Computing in Clinical Trials Revenue by Country (2021-2026)
- 11.6.3 Asia Cloud Computing in Clinical Trials Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cloud Computing in Clinical Trials Revenue (2021-2032)
- 12.2 SAMEA Cloud Computing in Clinical Trials Revenue by Type (2021-2032)
- 12.2.1 SAMEA Cloud Computing in Clinical Trials Revenue by Type (2021-2026)
- 12.2.2 SAMEA Cloud Computing in Clinical Trials Revenue by Type (2027-2032)
- 12.3 SAMEA Cloud Computing in Clinical Trials Revenue Share by Type (2021-2032)
- 12.4 SAMEA Cloud Computing in Clinical Trials Revenue by Application (2021-2032)
- 12.4.1 SAMEA Cloud Computing in Clinical Trials Revenue by Application (2021-2026)
- 12.4.2 SAMEA Cloud Computing in Clinical Trials Revenue by Application (2027-2032)
- 12.5 SAMEA Cloud Computing in Clinical Trials Revenue Share by Application (2021-2032)
- 12.6 SAMEA Cloud Computing in Clinical Trials Revenue by Country
- 12.6.1 SAMEA Cloud Computing in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Cloud Computing in Clinical Trials Revenue by Country (2021-2026)
- 12.6.3 SAMEA Cloud Computing in Clinical Trials Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst